Correlation Between Diamyd Medical and Genertec Universal

Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and Genertec Universal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and Genertec Universal into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Diamyd Medical AB and Genertec Universal Medical, you can compare the effects of market volatilities on Diamyd Medical and Genertec Universal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of Genertec Universal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and Genertec Universal.

Diversification Opportunities for Diamyd Medical and Genertec Universal

0.68

Correlation Coefficient

Diamyd Medical  Genertec Universal

Poor diversification

The 3 months correlation between Diamyd and Genertec is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and Genertec Universal Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genertec Universal and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with Genertec Universal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genertec Universal has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and Genertec Universal go up and down completely randomly.

Pair Corralation between Diamyd Medical and Genertec Universal

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 0.97 times more return on investment than Genertec Universal. However, Diamyd Medical AB is 1.03 times less risky than Genertec Universal. It trades about 0.32 of its potential returns per unit of risk. Genertec Universal Medical is currently generating about 0.04 per unit of risk. If you would invest  134.00  in Diamyd Medical AB on October 11, 2024 and sell it today you would earn a total of  28.00  from holding Diamyd Medical AB or generate 20.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Diamyd Medical AB  vs.  Genertec Universal Medical

Diamyd Medical AB

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.

Genertec Universal

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Genertec Universal Medical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Genertec Universal may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Diamyd Medical and Genertec Universal

The main advantage of trading using opposite Diamyd Medical and Genertec Universal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, Genertec Universal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genertec Universal will offset losses from the drop in Genertec Universal's long position.

The idea behind Diamyd Medical AB and Genertec Universal Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.